Full name
INPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
InPharm
Abrahama 1-3, 81-352 Gdynia
TAX ID5862281100
Phone+48586603090
Rate company:
InPharm
TAX ID5862281100
KRS0000449271
Share capital5,000.00 zł
address
Abrahama 1-3, 81-352 Gdynia
Phone number
+48586603090Categories
Main category
Register Data
NIP
5862281100
REGON
221823549
KRS
0000449271
Legal form
limited liability company
ALEO.com Registration Date
2013-10-18
Register Address
UL. ABRAHAMA 1-3, 81-352 GDYNIA
Date of registration in KRS
2013-01-30
Date of commencement of economic activity
2013-01-30
Act signature
GD.VIII NS-REJ.KRS/8828/25/243
Pkd codes
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
72 - Scientific research and development activities
Payer VAT status
Active
Vat list bank account(s)
PL12 1090 1056 0000 0001 5619 0393 
PL38 1160 2202 0000 0005 8586 0526 PL22 1160 2202 0000 0005 8585 9553 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | -0,1 | 0 | -0 | -101 450,5 |
EBITDA | ||||
Short time liabilities | ||||
Income tax | 0 | 0 | 0 | 0 |
Equity capital | -0,2 | -0,2 | -0,3 | -23,4 |
Operating profit (EBIT) | ||||
Assets | 0,2 | 0,2 | 1 | 431,5 |
Net profit (loss) | -0,1 | 0 | -0 | -101 450,5 |
Cash | ||||
Net income from sale | ||||
Liabilities and provisions for liabilities | 0,4 | 0,4 | 1,3 | 218,9 |
Working assets | 0,2 | 0,2 | 1 | 422,7 |
Basic operational activity income | 1,1 | 1 | 0,6 | -42 |
Depreciation | ||||
% | % | % | p.p. | |
Profitability of capital | ||||
Equity capital to total assets | -99,5 | -108,8 | -25,3 | 83,5 |
Gross profit margin | -5,8 | 0 | -8,3 | -8,3 |
EBITDA Margin | ||||
Days | Days | Days | Days | |
Short term commitment turnover cycle |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
KGU Konsult Wojciech Guzowski
Warszawa
Katarzyna Zielińska-Mika APTEKARZ
Nakło nad Notecią
APIOMEDYKA Zaopatrzenie Medyczne
Koszalin
Miodla Poland sp. z o.o.
Pszczyna
Mi-Ro S.C.
Stróża
Eres Medical sp. z o.o.
Płouszowice Kolonia
PROMEDIQ A Sp. z o.o.
Gdynia